Related Experiment Video
Updated: Oct 26, 2025

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
Published on: April 26, 2024
Unlocking the bacterial membrane as a therapeutic target for next-generation antimicrobial amphiphiles
Devashish Mehta1, Varsha Saini1, Bharti Aggarwal1
1Laboratory of Nanotechnology and Chemical Biology, Regional Center for Biotechnology, Faridabad, Haryana, 121001, India.
Abstract:
Gram-positive bacteria like Enterococcus faecium and Staphylococcus aureus, and Gram-negative bacteria like Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter Spp. are responsible for most of fatal bacterial infections. Bacteria present a handful of targets like ribosome, RNA polymerase, cell wall biosynthesis, and dihydrofolate reductase. Antibiotics targeting the protein synthesis like aminoglycosides and tetracyclines, inhibitors of RNA/DNA synthesis like fluoroquinolones, inhibitors of cell wall biosynthesis like glycopeptides and β-lactams, and membrane-targeting polymyxins and lipopeptides have shown very good success in combating the bacterial infections. Ability of the bacteria to develop drug resistance is a serious public health challenge as bacteria can develop antimicrobial resistance against newly introduced antibiotics that enhances the challenge for antibiotic drug discovery. Therefore, bacterial membranes present a suitable therapeutic target for development of antimicrobials as bacteria can find it difficult to develop resistance against membrane-targeting antimicrobials. In this review, we present the recent advances in engineering of membrane-targeting antimicrobial amphiphiles that can be effective alternatives to existing antibiotics in combating bacterial infections.
Insights
Bacterial infections pose a threat, but targeting bacterial membranes with novel amphiphiles offers a promising strategy against drug-resistant bacteria. This approach presents an alternative to traditional antibiotics.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Fatal bacterial infections are caused by Gram-positive (e.g., Enterococcus faecium, Staphylococcus aureus) and Gram-negative bacteria (e.g., Klebsiella pneumoniae, Acinetobacter baumannii).
- Existing antibiotics target essential bacterial components like ribosomes, RNA polymerase, cell wall biosynthesis, and dihydrofolate reductase.
- Antimicrobial resistance is a significant public health challenge, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review recent advances in the engineering of membrane-targeting antimicrobial amphiphiles.
- To explore these amphiphiles as potential alternatives to conventional antibiotics.
- To address the challenge of bacterial drug resistance.
Main Methods:
- Review of current scientific literature on antimicrobial amphiphile development.
- Analysis of bacterial membrane as a therapeutic target.
- Discussion of engineering strategies for novel antimicrobial agents.
Main Results:
- Bacterial membranes are a viable target for antimicrobial development.
- Bacteria exhibit difficulty in developing resistance to membrane-targeting agents.
- Engineered antimicrobial amphiphiles show potential as effective alternatives.
Conclusions:
- Membrane-targeting antimicrobial amphiphiles represent a promising avenue for combating bacterial infections.
- These novel agents may overcome existing antibiotic resistance mechanisms.
- Further research into engineered amphiphiles is crucial for developing next-generation antimicrobials.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Lytic Cycle of Bacteriophages
Gene Regulation in Microbial Communities: Quorum Sensing
Bioavailability Enhancement: Drug Permeability Enhancement
Biological Methods for Microbial Control
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

